Portnoy Mark L. 4/A

4/A · CRYO CELL INTERNATIONAL INC · Filed Feb 8, 2022

Form 4/AAmended

Period: 2021-12-22

DirectorCo-CEO10% Owner

Transactions

Award
Stock Option
2021-12-22$12.27/sh+100,000$1,227,000→ 100,000 total
Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying)
Award
Stock Option
2021-12-22$13.50/sh+20,000$270,000→ 20,000 total
Exercise: $13.50From: 2021-12-22Exp: 2024-12-22→ Common Stock (20,000 underlying)

Holdings

Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying)
20,000
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common Stock (22,222 underlying)
22,222
Common Stock
(indirect: By 401(k))
42,266
Common Stock
762,514
Stock Option
Exercise: $3.14From: 2016-04-15Exp: 2026-04-15→ Common Stock (59,459 underlying)
59,459
Common Stock
(indirect: By Partnership)
71,529
Stock Option
Exercise: $7.92From: 2018-03-08Exp: 2028-03-08→ Common Stock (20,000 underlying)
20,000

Footnotes (4)

[F1]Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
[F2]Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.
[F3]The reporting person is amending his Form 4 filed on December 27, 2021 to correct an inadvertent error in reporting the exercise price of the Incentive Stock Option due to the reporting person being a 10% shareholder. Stock options vest 1/3 on the date of grant, 1/3 on December 22, 2022 and 1/3 on December 22, 2023.
[F4]Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.

Documents

1 file